Free Trial

Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Intuitive Surgical logo with Medical background

BNP PARIBAS ASSET MANAGEMENT Holding S.A. cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 814,529 shares of the medical equipment provider's stock after selling 52,559 shares during the period. Intuitive Surgical accounts for 1.0% of BNP PARIBAS ASSET MANAGEMENT Holding S.A.'s portfolio, making the stock its 12th largest position. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned approximately 0.23% of Intuitive Surgical worth $400,153,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently added to or reduced their stakes in ISRG. Healthcare of Ontario Pension Plan Trust Fund grew its position in Intuitive Surgical by 10,606.9% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 12,420 shares of the medical equipment provider's stock valued at $4,957,000 after buying an additional 12,304 shares in the last quarter. CreativeOne Wealth LLC grew its position in Intuitive Surgical by 41.2% in the 1st quarter. CreativeOne Wealth LLC now owns 2,324 shares of the medical equipment provider's stock valued at $927,000 after buying an additional 678 shares in the last quarter. Axxcess Wealth Management LLC grew its position in Intuitive Surgical by 18.1% in the 1st quarter. Axxcess Wealth Management LLC now owns 10,551 shares of the medical equipment provider's stock valued at $4,211,000 after buying an additional 1,618 shares in the last quarter. Advisors Asset Management Inc. grew its position in Intuitive Surgical by 18.1% in the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider's stock valued at $2,945,000 after buying an additional 1,129 shares in the last quarter. Finally, Sheaff Brock Investment Advisors LLC grew its position in Intuitive Surgical by 1.8% in the 1st quarter. Sheaff Brock Investment Advisors LLC now owns 2,265 shares of the medical equipment provider's stock valued at $904,000 after buying an additional 39 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of ISRG opened at $541.82 on Thursday. The company has a market capitalization of $192.99 billion, a price-to-earnings ratio of 87.11, a P/E/G ratio of 5.30 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $544.38. The business's 50-day moving average is $502.44 and its 200-day moving average is $461.26.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

ISRG has been the subject of a number of research analyst reports. Leerink Partners upped their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an "overweight" rating in a report on Friday, October 18th. Citigroup upped their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a "buy" rating in a report on Friday, October 18th. Finally, Evercore ISI reissued a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $524.61.

Check Out Our Latest Analysis on ISRG

Insider Buying and Selling

In related news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This represents a 93.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Jamie Samath sold 269 shares of the business's stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares of the company's stock, valued at $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 91,178 shares of company stock worth $45,897,071. Insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Intuitive Surgical right now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines